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We present a case of giant cavernous hemangioma of
the liver with disseminated intravascular coagulo-
pathy (Kasabach-Merritt syndrome) which was
cured by enucleation. The 51 year old woman
presented with increased abdominal girth and easy
bruisability. Workup elsewhere revealed a massive
hepatic hemangioma and she was started on radia-
tion therapy to the lesion and offered an orthotopic
liver transplant. After careful preoperative prepara-
tion, we felt that resection was possible and she
underwent a successful enucleation. The operation
and postoperative course were complicated by
bleeding but she recovered and remains well in
followup after 6 months. All coagulation param-
eters have returned to normal. Enucleation should
be considered the treatment of choice for hepatic
hemangiomas, including those presenting with
Kasabach-Merritt syndrome. The benefits of en-
ucleation as compared to liver transplantation for
these lesions are discussed.
Keywords: Kasabach-Merritt syndrome, enucleation, he-
mangioma
INTRODUCTION
In 1940, Kasabach and Merritt reported a case of
thrombocytopenic purpura associated with a
rapidly growing cutaneous capillary hemangio-
ma in a 2-month old child [1]. To date more than
100 cases of Kasabach-Merritt syndrome have
been described, most in infants with cutaneous
hemangiomas. The cardinal features of the
Kasabach-Merritt syndrome include an enlarg-
ing hemangioma, thrombocytopenia and mi-
croangiopathic hemolytic anemia with acute or
chronic consumptive coagulopathy. Hepatic
cavernous hemangiomas presenting with this
syndrome have been infrequently encountered
and their management is challenging and
controversial. Recently, two cases of orthotopic
liver transplant for unresectable hepatic
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hemangiomas with Kasabach- Merritt syn-
drome have been described [2,3]. We report a
case of successful hepatic tumor enucleation
for a patient with Kasabach-Merritt syndrome
who was considered unresectable and offered
liver transplantation before referral.
Case Report
A 51-year-old female was referred to a hospital
for evaluation of increased abdominal girth and
fatigue over a 6 month period. In addition, she
noticed she had been bruising easily for approxi-
mately 2 years. An investigation, including ab-
dominal ultrasound, computed tomographic
(CT) scan and liver-spleen scan, revealed a large
cavernous hemangioma of the liver. Routine
blood tests revealed a prothrombin time of 15-
16 seconds (INR 1.3-1.4), a platelet count of
92,000/mm
3 and a white blood cell count of
2200/mm3. Careful hematologic evaluation re-
vealed a low fibrinogen level of 69mg/dL with
an elevated D-dimer level of 8.0 mg/dl. The pa-
tient’s liver function tests were noted to be nor-
mal and her albumin level was 4.3 g/dl. Other
medical history was significant only for hyster-
ectomy at the age of 28 for heavy bleeding. She
had been on estrogen replacement for 10 years.
The patient was evaluated by an outside in-
stitution and was felt to be not a suitable candi-
date for liver resection. She was offered a
liver transplant and was started on external
beam radiation to the lesion. Further investiga-
tions were performed consisting of magnetic
resonance imaging (MRI), celiac and superior
mesenteric artery angiography, and inferior
vena cava and right hepatic venography. These
studies revealed an extremely large mass arising
from the liver and occupying the entire right
side of the abdomen (Fig. 1). Cross sectional
imaging revealed the entire left liver to be
replaced by this mass. In addition, a separate
large mass was present in the caudate lobe
(Fig. 2). There was no aberrant arterial supply
to the liver. The left portal vein did not fill
and there was compression of the main portal
vein. There was severe compression of the
retrohepatic inferior vena cava (Fig. 3). The left
hepatic vein was completely compressed but the
right hepatic vein was widely patent (Fig. 4). It
was considered that resection was feasible.
After preoperative transfusion of platelets and
fresh frozen plasma, laparotomy was performed.
A very large hemangioma extended from the
cupula of the diaphragm down into the pelvis
bilaterally. The large tumor occupied segments I,
II, III, IV, V and VIII and was extremely vascular.
The left lobe of the liver was first fully mobilized
and the right lobe partially mobilized. The
hepatic artery was located, noted to be marked-
ly enlarged and cross clamped. The liver was
then manually compressed in order to partially
empty it of blood, decrease its size and make it
more manageable. The right anterior branch of
the hepatic artery was ligated. The left hepatic
artery was divided between clamps and the left
branch of the portal vein was transected. The
left hepatic duct was circled with a suture and
divided. The hepatic veins could not be reached
at this stage of the procedure and it was decided
to enucleate the tumor between segments V and
VIII and VI and VII. The left and middle hepatic
veins were divided as they were reached and seg-
ments II, III, IV,V and VIII were removed as an
extended left hepatic lobectomy. The caudate
lobe, which was markedly enlarged with tumor,
was now mobilized from the underlying vena
cava and removed almost in its entirety but a
small portion of the hemangioma was left just
above the right hepatic vein. Final hemostasis
was secured with suture ligation and the Argon
beam coagulator. Blood loss during this pro-
cedure was considerable and amounted to
about 10 liters. The patient was transferred to the
recovery room in stable condition. Approxi-
mately one hour after reaching the recovery
room, the patient became hypotensive and was
noted to have an expanding abdomen. The
patient was taken back to the operating room
and exploration revealed multiple areas ofHEMANGIOMA WITH KASABACH-MERRITT SYNDROME 415
FIGURE Coronal section of MRI showing large mass in white (long arrow) which occupies most of the abdominal cavity.
Short arrow represents separate tumor mass in caudate lobe.
oozing from the raw surface of the liver. It was
quickly determined that this represented coagu-
lopathic bleeding instead of surgical bleeding
and the decision was made to pack the abdo-
men with abdominal pads and return to the In-
tensive Care Unit. The patient required two
further reoperations over the next four days for
removal of packs and further hemostasis.
She recovered and was discharged home
after 21 days in the hospital. She remains well
in follow up with resolution of her neutropenia
and coagulopathy and reports a significant im-
provement in her quality of life.
DISCUSSION
Hemangiomas are the most common benign
tumors of the liver. In autopsy series the
incidence ranges from 0.6 to 7%. Most416 S.N. HOCHWALD AND AND L. H. BLUMGART
FIGURE 2 Cross section of MRI demonstrating mass in white which occupies entire left lobe of liver and segments V and VIII
of right lobe. Short arrow shows caudate mass. Long arrows demonstrates right hepatic vein.
hemangiomas are small, solitary and are sel-
dom symptomatic. Giant hemangiomas are de-
fined as those larger than 4cm and occur
most frequently in women in the fourth and
fifth decades and can reach enormous propor-
tions [4]. These may present with symptoms
varying from slight discomfort in the upper ab-
domen to spontaneous rupture of the heman-
gioma. More rarely, as in the current case,
hemangiomas present with consumption
coagulopathy [5].
The primary pathophysiologic event of the
Kasabach-Merritt syndrome is platelet trapping
within the vascular lesion. It may be acute and
massive or chronic and low grade. If a compen-
satory increase in bone marrow megakaryocyte
production does not occur, then thrombocyto-
penia develops. 131I-labeled fibrinogen studies
also demonstrate accumulation of this hemo-
static factor in lesions [6].
Non surgical treatment of cavernous heman-
giomas of the liver include radiation therapy
and embolization and have had mixed success.
Reports utilizing radiation therapy have de-
scribed a partial or complete regression of symp-
toms in the majority of patients, albeit with
rather sketchy details and only clinical assess-
ment of response in the early cases [7]. Data
supporting objective tumor regression with
radiation therapy are lacking. The optimal dose
of radiation is not firmly established but it
should be the minimal dose which will alleviateHEMANGIOMA WITH KASABACH-MERRITT SYNDROME 417
FIGURE 3 Venogram of inferior vena cava is shown. Short arrow represents vena cava below tumor mass. Long arrow
represents compression of vena cava with small patent lumen. Note presence of venous collaterals due to chronic caval
compression.
symptoms, given that this is the major goal of
therapy. Most investigators report utilizing 20-
30Gy (in 3-4 weeks) [7]. Given the relative
radioresistance of normal vascular endothelium,
the mechanism of radiation effect on this tumor
is unknown. There is no evidence that radiation
therapy relieves the coagulopathy present in
patient with giant hepatic hemangiomas and
Kassabach-Merritt syndrome. In the case pre-
sented here there was no improvement in any
symptoms with low dose radiation treatment.
The role of arterial emoblization as a treatment
for primary and secondary hepatic neoplasms is
well established [8]. For hepatic hemangiomas
and Kasabach-Merritt syndrome there are lim-
ited data, but one report utilizing intravenous
cryoprecipitate plus infusion of intra-arterial
thrombin and aminocaproic acid resulted in418 S.N. HOCHWALD AND AND L. H. BLUMGART
FIGURE 4 Hepatic venogram is demonstrated. Short arrow represents catheter entering hepatic veins. Long arrow represents
right hepatic vein which is patent. The left and middle hepatic veins were not visualized due to compression.
complete stasis within the hepatic hemangioma
[9]. Unfortunately, in most cases, embolization
is only temporarily effective in reducing the
size of the hemangioma and improving the
bleeding diathesis. As recanalization occurs,
there is a concomitant recurrence of the coagu-
lopathy [9,10]. Thus, the drawbacks to emboli-
zation are recanalization and the possibility of a
significant reduction in blood supply to an
organ, resulting in ischemia and possibly infarc-
tion or necrosis.
While surgery appears to be the most effective
treatment, whether giant cavernous hemangio-
ma of the liver should be treated conservatively
or removed is controversial. Even for sympto-
matic giant hemangiomas, some authors have
advocated long-term follow up. One of the
reasons given for this policy is that the morbid-
ity and mortality rates associated with major
liver resection have been suggested by some as
prohibitive. The almost negligible mortality rate
recently reported for elective resection in spe-
cialized centers does not support this view [4,
11-13]. Perioperative deaths generally occur
during the rare case of emergent treatment of
spontaneous bleeding or rupture [14]. Certainly,
in those Patients presenting with hematologic
decompensation, resection should be performed.
Case reports have described orthotopic liver
transplantation for giant hemangioma of the
liver and Kasabach-Merritt syndrome. In these
two reports, hepatectomy was described as aHEMANGIOMA WITH KASABACH-MERRITT SYNDROME 419
difficult procedure because of the bulk and
weight of the tumor. Blood loss was consider-
able in these reports with transfusion of 14
units of blood in one case and 17liters of
blood products in the other [2,3]. In one of the
two cases, a reoperation was necessary due to
hemorrhage. While operative mortality for liver
transplantation has decreased considerably since
its inception, operative mortality is still 10% and
5-year survival approximately 80% for benign
disease [15]. In addition, patients must take
lifelong medication with frequent follow up.
If surgical treatment is considered, we feel
that surgical enucleation rather than liver trans-
plantation is the procedure of choice for caver-
nous hepatic hemangiomas including those
presenting with the Kasabach-Merritt syn-
drome. This is based on the assumption that
coagulopathy and tumor size make it a techni-
cally difficult procedure whether enucleation or
liver transplantation are performed. In specia-
lized centers, enucleation should be associated
with a mortality no higher than that for liver
transplantation without the need for lifelong
medication and follow up. The extensive blood
supply of these lesions requires a meticulous
and standardized approach. This has been
described elsewhere and depends on prior con-
trol of the major extrahepatic feeding vessels,
and dissection within the relatively less well
perfused rim of compressed tissue through
which the feeding vessels supply the lesion [4].
In one report, median blood loss with enuclea-
tion for 11 large hemangiomas was 800 ml. Even
when the size of the tumor means that most of
the right or left lobe has been removed, the
disturbance of liver function is insignificant.
The technique of enucleation allows safe re-
moval of even very large lesions in most cases.
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